|
|
|
Insider
Information: |
Hsiao Jane Ph D |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
50,158,203 |
|
Indirect Shares
|
33,836,183 |
|
|
Direct
Value |
$48,627,270 |
|
|
Indirect Value
|
$17,247,610 |
|
|
Total
Shares |
83,994,386 |
|
|
Total
Value |
$65,874,880 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-64.3%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Asensus Surgical Inc |
ASXC |
Director |
2021-07-01 |
336,895 |
2021-07-01 |
96,746 |
Premium* |
|
Protalix Biotherapeutics |
PLX |
Director |
2007-01-31 |
1,134,060 |
|
0 |
Premium* |
|
Opko Health Inc |
OPK |
|
2024-07-24 |
28,499,880 |
2024-07-24 |
5,127,404 |
Premium* |
|
Prolor Biotech Inc |
PBTH |
Director |
2013-08-29 |
0 |
2013-08-29 |
0 |
Premium* |
|
Non Invasive Monitoring Systems ... |
NIMU |
Interim CEO, Director,... |
2018-12-21 |
16,752,074 |
2018-12-21 |
20,883,660 |
Premium* |
|
Sorrento Therapeutics Inc |
SRNE |
Director |
|
0 |
2010-01-25 |
2,231,719 |
Premium* |
|
Cocrystal Pharma |
COCP |
|
2016-03-15 |
3,435,294 |
2016-03-15 |
5,496,654 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
94 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PLX |
Protalix Biotherapeutics |
Director |
|
2007-01-31 |
4 |
OE |
$1.38 |
$355,496 |
D/D |
258,355 |
1,134,060 |
0 |
- |
|
OPK |
Opko Health Inc |
Director |
|
2007-03-27 |
4/A |
A |
$0.00 |
$0 |
D/D |
11,604,144 |
11,604,144 |
0 |
- |
|
OPK |
Opko Health Inc |
Director |
|
2007-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
11,604,144 |
4,095,581 |
0 |
- |
|
OPK |
Opko Health Inc |
Chief Technology Officer |
|
2007-07-13 |
4 |
B |
$1.80 |
$1,800,000 |
D/D |
1,000,000 |
5,095,581 |
2.81 |
- |
|
ASXC |
Asensus Surgical Inc |
Director |
|
2007-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
215,000 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Director |
|
2007-09-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,588,965 |
2,803,965 |
0 |
- |
|
OPK |
Opko Health Inc |
Chief Technology Officer |
|
2007-12-04 |
4 |
B |
$1.84 |
$7,500,000 |
D/D |
4,076,087 |
9,171,668 |
2.81 |
- |
|
OPK |
Opko Health Inc |
Chief Technology Officer |
|
2008-02-11 |
4 |
B |
$1.80 |
$3,600,000 |
I/I |
2,000,000 |
17,490,546 |
2.66 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman and CTO |
|
2008-05-08 |
4 |
B |
$1.25 |
$625,000 |
I/I |
500,000 |
500,000 |
2.66 |
- |
|
ASXC |
Asensus Surgical Inc |
Director |
|
2008-05-28 |
4 |
B |
$2.15 |
$129,000 |
I/I |
60,000 |
60,000 |
2.25 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman and CTO |
|
2008-07-02 |
4 |
B |
$1.24 |
$69,517 |
I/I |
53,000 |
553,000 |
1.99 |
- |
|
OPK |
Opko Health Inc |
See Remarks |
|
2008-08-08 |
4 |
A |
$1.11 |
$1,999,998 |
I/I |
1,801,800 |
2,354,800 |
0 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman and CTO |
|
2009-07-27 |
4 |
B |
$1.75 |
$17,500 |
I/I |
10,000 |
2,364,800 |
2.56 |
- |
|
PBTH |
Prolor Biotech Inc |
Director |
|
2010-05-20 |
4 |
OE |
$1.00 |
$368,523 |
I/I |
368,523 |
2,179,856 |
0 |
- |
|
PBTH |
Prolor Biotech Inc |
Director |
|
2010-05-20 |
4 |
OE |
$0.50 |
$380,000 |
D/D |
760,000 |
1,811,333 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Chairman of the Board |
|
2010-06-15 |
4 |
B |
$1.00 |
$1,300,000 |
I/I |
1,300,000 |
1,360,000 |
2.25 |
- |
|
ASXC |
Asensus Surgical Inc |
Chairman of the Board |
|
2010-09-10 |
4 |
OE |
$1.00 |
$477,209 |
I/I |
477,209 |
1,837,209 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Chairman of the Board |
|
2010-09-10 |
4 |
A |
$0.00 |
$0 |
I/I |
76,261 |
1,913,470 |
0 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2011-01-21 |
4 |
B |
$3.55 |
$710,000 |
I/I |
200,000 |
2,564,800 |
2.66 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2011-03-09 |
4 |
A |
$3.75 |
$1,998,750 |
I/I |
533,000 |
3,097,800 |
0 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2011-10-05 |
4 |
B |
$3.60 |
$4,320,000 |
I/I |
1,200,000 |
4,297,800 |
2.64 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2011-12-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
831,052 |
24,455,147 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Chairman of the Board |
|
2012-02-17 |
4 |
B |
$0.40 |
$1,800,000 |
D/D |
4,500,000 |
7,303,965 |
3.92 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2012-03-29 |
4 |
B |
$4.68 |
$46,957 |
D/D |
10,000 |
17,890,231 |
3.23 |
- |
|
PBTH |
Prolor Biotech Inc |
Director |
|
2012-04-12 |
4 |
OE |
$2.50 |
$158,333 |
D/D |
63,333 |
1,874,666 |
0 |
- |
|
94 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|